1887
Surveillance Open Access
Like 0

Abstract

BACKGROUND

Surveillance of severe acute respiratory infections (SARI) using ICD-10 codes from electronic health records (EHR) lacks consensus on optimal case-defining codes.

AIM

We determined codes that maximise sensitivity (Se) and positive predictive value (PPV) for SARI associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus and respiratory syncytial virus (RSV) in Denmark, Iceland, Malta, Norway and Spain.

METHODS

We included hospitalisations from week 21/2021 to 39/2023, with ICD-10 diagnostic codes for respiratory disease (three-character codes J00–J99) or COVID-19 (U07.1, U07.2, country-specific codes for Denmark). We assessed Se and PPV of individual codes against laboratory results. Based on Se and PPV rank-sum, we selected the top 10 codes and combined them into 10 sets per pathogen. We identified sets that maximised the clinical utility index (CUI = Se × PPV), categorised as excellent (≥ 0.81), good (0.64–0.80), satisfactory (0.49–0.63) and poor (< 0.49).

RESULTS

We assessed 395,163 hospitalisations for SARI-SARS-CoV-2, 313,418 for SARI-influenza and 192,936 for SARI-RSV, all tested. For SARI-SARS-CoV-2, code U07.1 (B34.2A, B97.2A for Denmark) had excellent utility in Denmark, Malta, Norway, Spain (≥ 0.82), and good utility in Iceland (0.79). For SARI-influenza, J09, J10 and J11 performed excellently in Denmark, Norway, Spain (≥ 0.83), satisfactorily in Malta (0.52), and poorly in Iceland (0.43). For SARI-RSV, J12, J20 and J21 achieved highest CUI but had poor utility (0.17–0.34).

CONCLUSIONS

COVID-19- and influenza-specific three-character ICD-10 codes accurately identified SARI associated with SARS-CoV-2 and influenza virus. For SARI-RSV, four-character codes should be explored. We recommend context-specific assessments in countries adopting EHR-based surveillance.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.27.2400748
2025-07-10
2025-07-12
/content/10.2807/1560-7917.ES.2025.30.27.2400748
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/27/eurosurv-30-27-3.html?itemId=/content/10.2807/1560-7917.ES.2025.30.27.2400748&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations. Epidemiological update: 2023 Dec 15. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/news-events/acute-respiratory-infections-eueea-epidemiological-update-and-current-public-health
  2. World Health Organization (WHO). Global Influenza Programme. WHO surveillance case definitions for ILI and SARI. Geneva: WHO. [Accessed: 16 Sep 2024]. Available from: https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari
  3. European Centre for Disease Prevention and Control (ECDC). Vaccine Effectiveness, Burden and Impact Studies (VEBIS). Stockholm: ECDC. [Accessed: 10 Jun 2024]. Available from: https://www.ecdc.europa.eu/en/infectious-disease-topics/related-public-health-topics/immunisation-and-vaccines/vaccine-0
  4. European Centre for Disease Prevention and Control (ECDC). ECDC accession support to the Western Balkans and Türkiye. Stockholm: ECDC; [Accessed: 10 Jun 2024]. Available from: https://www.ecdc.europa.eu/en/about-ecdc/what-we-do/partners-and-networks/international-cooperation/cooperation-western-balkans-turkiye
  5. European Commission (EC). Design and implementation of multinational surveillance systems using routinely collected electronic health records in EU/EEA. Brussels: EC; 2021. Available from: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/9819
  6. European Respiratory Virus Surveillance Summary (ERVISS). Overview of respiratory virus epidemiology in the EU/EEA. Stockholm: European Centre for Disease Prevention and Control, Copenhagen: World Health Organization European Region. [Accessed: 16 Sep 2024]. Available from: https://erviss.org
  7. Marbus SD, van der Hoek W, van Dissel JT, van Gageldonk-Lafeber AB. Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges. Public Health Pract (Oxf). 2020;1:100014.  https://doi.org/10.1016/j.puhip.2020.100014  PMID: 34171043 
  8. Cauchi JP, Borg ML, Džiugytė A, Attard J, Melillo T, Zahra G, et al. Digitalizing and upgrading severe acute respiratory infections surveillance in Malta: system development. JMIR Public Health Surveill. 2022;8(12):e37669.  https://doi.org/10.2196/37669  PMID: 36227157 
  9. Whittaker R, Toikkanen S, Dean K, Lyngstad TM, Buanes EA, Kløvstad H, et al. A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022. Euro Surveill. 2023;28(33):2200888.  https://doi.org/10.2807/1560-7917.ES.2023.28.33.2200888  PMID: 37589591 
  10. Seppälä E, Bøås H, Dahl J, Stålcrantz J, Stecher M, Tønnessen R, et al. Registry-based surveillance of severe acute respiratory infections in Norway during 2021-2024. Influenza Other Respir Viruses. 2025;19(2):e70080.  https://doi.org/10.1111/irv.70080  PMID: 39950571 
  11. Torres AR, Gómez V, Kislaya I, Rodrigues AP, Fernandes Tavares M, Pereira AC, et al. Monitoring COVID-19 and influenza: the added value of a severe acute respiratory infection surveillance system in Portugal. Can J Infect Dis Med Microbiol. 2023;2023:6590011.  https://doi.org/10.1155/2023/6590011  PMID: 36846348 
  12. Buda S, Tolksdorf K, Schuler E, Kuhlen R, Haas W. Establishing an ICD-10 code based SARI-surveillance in Germany - description of the system and first results from five recent influenza seasons. BMC Public Health. 2017;17(1):612.  https://doi.org/10.1186/s12889-017-4515-1  PMID: 28666433 
  13. El-Khatib Z, Richter L, Reich A, Benka B, Assadian O. Implementation of a surveillance system for severe acute respiratory infections at a tertiary care hospital in Austria: protocol for a retrospective longitudinal feasibility study. JMIR Res Protoc. 2023;12(1):e47547.  https://doi.org/10.2196/47547  PMID: 37535414 
  14. Brady M, Duffy R, Domegan L, Salmon A, Maharjan B, O’Broin C, et al. Establishing severe acute respiratory infection (SARI) surveillance in a sentinel hospital, Ireland, 2021 to 2022. Euro Surveill. 2023;28(23):2200740.  https://doi.org/10.2807/1560-7917.ES.2023.28.23.2200740  PMID: 37289427 
  15. World Health Organization (WHO). ICD-10. International statistical classification of diseases and related health problems 10th revision. Geneva: WHO. [Accessed: 3 May 2024]. Available from: https://icd.who.int/browse10/2019/en
  16. Mitchell AJ. Sensitivity × PPV is a recognized test called the clinical utility index (CUI+). Eur J Epidemiol. 2011;26(3):251-2, author reply 252.  https://doi.org/10.1007/s10654-011-9561-x  PMID: 21442261 
  17. Østergaard SD, Dinesen PT, Foldager L. Quantifying the value of markers in screening programmes. Eur J Epidemiol. 2010;25(3):151-4.  https://doi.org/10.1007/s10654-010-9430-z  PMID: 20151178 
  18. Mitchell JA. How to: analyse a screening or diagnostic study. Psycho-oncology.info; 2009. Available from: https://www.psycho-oncology.info/PG_analyse_ajmitchell.pdf
  19. Moura CS, Neville A, Liao F, Wen B, Razak F, Roberts S, et al. Validity of hospital diagnostic codes to identify SARS-CoV-2 infections in reference to polymerase chain reaction results: a descriptive study. CMAJ Open. 2023;11(5):E982-7.  https://doi.org/10.9778/cmajo.20230033  PMID: 37875313 
  20. Moura CS, Morrison LJ, Hohl CM, Grant L, Pilote L, Neville A, et al. Administrative data ICD-10 diagnostic codes identifies most lab-confirmed SARS-CoV-2 admissions but misses many discharged from the Emergency Department. Sci Rep. 2024;14(1):6008.  https://doi.org/10.1038/s41598-023-49501-7  PMID: 38472258 
  21. Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, et al. Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS One. 2021;16(1):e0244746.  https://doi.org/10.1371/journal.pone.0244746  PMID: 33411792 
  22. Lozano Álvarez M, Moya Garcés A, Imaz Goienetxea L, Lameiras Azevedo AS, Otero Barros MT, Ruiz de Porras Rubio C, et al. Validez de la definición de caso de Infección Respiratoria Aguda Grave basada en códigos CIE-10 en cuatro comunidades autónomas (España, 2021-2023). [Validity of case definitions for Severe Acute Respiratory Infection based on ICD-10 codes in four autonomous communities (Spain, 2021-2023)]. Rev Esp Salud Publica. 2025;99:e202505025. Spanish. PMID: 40503697 
  23. Davis W, Duque J, Huang QS, Olson N, Grant CC, Newbern EC, et al. Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012-2016. J Infect. 2021;84(2):216-26.  https://doi.org/10.1016/j.jinf.2021.12.012.  PMID: 34953903 
  24. Wabe N, Li L, Lindeman R, Post JJ, Dahm MR, Li J, et al. Evaluation of the accuracy of diagnostic coding for influenza compared to laboratory results: the availability of test results before hospital discharge facilitates improved coding accuracy. BMC Med Inform Decis Mak. 2021;21(1):168.  https://doi.org/10.1186/s12911-021-01531-9  PMID: 34022851 
  25. Mihailovic N, Vasiljevic D, Milicic V, Luketina Sunjka M, Radovanovi S, Milicic B, et al. Discrepancy between admission and discharge diagnoses in central Serbia: analysis by the groups of International Classification of Diseases, 10th revision. Iran J Public Health. 2020;49(12):2348-55.  https://doi.org/10.18502/ijph.v49i12.4818  PMID: 34178741 
  26. Zikos D, Shrestha A, Fegaras L. Estimation of the mismatch between admission and discharge diagnosis for respiratory patients, and implications on the length of stay and hospital charges. AMIA Jt Summits Transl Sci Proc. 2019;2019:192-201. PMID: 31258971 
/content/10.2807/1560-7917.ES.2025.30.27.2400748
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error